Sunshine Biopharma (SBFM) Cash from Operations (QoQ) (2011 - 2026)
Sunshine Biopharma (SBFM) Cash from Operations (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Sunshine Biopharma | 1.52 Mn | -12.23 Mn | 2.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 55.70% |
| Mar 31, 2026 | -28.22% |
| Dec 31, 2025 | -122.04% |
| Sep 30, 2025 | 43.68% |
| Jun 30, 2025 | 23.76% |
| Mar 31, 2025 | 50.22% |
| Dec 31, 2024 | -151.02% |
| Sep 30, 2024 | 70.37% |
| Jun 30, 2024 | -43.72% |
| Mar 31, 2024 | -18.42% |
| Dec 31, 2023 | -488.18% |
| Sep 30, 2023 | 87.90% |
| Jun 30, 2023 | -104.21% |
| Mar 31, 2023 | 17.65% |
| Dec 31, 2022 | -99.92% |
| Sep 30, 2022 | -95.84% |
| Jun 30, 2022 | 56.00% |
| Mar 31, 2022 | -317.86% |
| Dec 31, 2021 | 48.05% |
| Sep 30, 2021 | 2.92% |